Apex Infusion, a Signal Hill, CA-based provider of ambulatory infusion therapy services, received an investment from FFL Partners.
The amount of the deal was not disclosed.
The company intends to use the funds to expand operations and its development efforts.
Founded in 2016, and led by CEO Moussie Hailemariam, Apex Infusion is dedicated to providing care to patients at home or in ambulatory settings. The company offers intravenous immunoglobulin, specialty infusion, total parental nutrition, and other therapeutic services, and coordinates professional interaction with its patient’s physicians, nurses and other health care providers.
Apex currently operates 11 locations in California.
FinSMEs
10/05/2024